HomeBLAB • CNSX
add
Britannia Life Sciences Inc
Previous close
$0.080
Year range
$0.030 - $0.12
Market cap
12.98M CAD
Avg Volume
193.27K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | — | — |
Net income | — | — |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.85M | 493.44% |
Total assets | 11.61M | -47.85% |
Total liabilities | 5.31M | -65.94% |
Total equity | 6.30M | — |
Shares outstanding | 162.25M | — |
Price to book | 2.00 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | — | — |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2000
Headquarters
Website
Employees
28
